PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival

Georgios Batsios(University of California, San Francisco), Sabrina M. Ronen(University of California, San Francisco)

Scientific Reports

July 19, 2019

10.1038/s41598-019-47021-x

Cited by 64

Related Papers

Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology

|Neoplasia|2018|446

Non-invasive in vivo assessment of IDH1 mutational status in glioma

|Nature Communications|2013|142

Applications of Magnetic Resonance in Model Systems: Cancer Therapeutics

|Neoplasia|2000|133

17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2

|Breast Cancer Research|2010|31

Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1Tesla

|Neuro-Oncology|2012|20